CFTR Modulators in Pregnancy and Postpartum - Trial NCT06302270
Access comprehensive clinical trial information for NCT06302270 through Pure Global AI's free database. This phase not specified trial is sponsored by Region Stockholm and is currently Recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 75 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Region Stockholm
Timeline & Enrollment
N/A
Mar 15, 2024
Jan 31, 2039
Primary Outcome
Health effects in the newborn infant
Summary
Observational study on women with Cystic Fibrosis treated with CFTR modulators during
 pregnancy and postpartum and their children. Registration on maternal health parameters and
 effects of CFTR-modulators in the newborn infant as well as effects of exposure through
 mother's own milk.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06302270
Non-Device Trial